TGFB1 and autoimmune encephalitis: In an experimental autoimmune encephalitis (EAE) model, C-PC decreased disease severity and upregulated key markers of regulatory T cells—FOXP3, CD25, IL-10, and TGF-β—while simultaneously exerting neuroprotective effects that mitigated myelin and axonal damage [49].